User profiles for M. Kool

Marcel Kool

PI, Hopp Children's Cancer Center Heidelberg & Princess Maxima Center Pediatric …
Verified email at dkfz.de
Cited by 72571

A family of drug transporters: the multidrug resistance-associated proteins

P Borst, R Evers, M Kool… - Journal of the National …, 2000 - academic.oup.com
… The HeLa cell results are from (89); the human ovarian carcinoma 2008 cell line results are
unpublished data from M. Kool and P. Borst; and the SW1573 (S1) human lung carcinoma …

Medulloblastomics: the end of the beginning

PA Northcott, DTW Jones, M Kool, GW Robinson… - Nature Reviews …, 2012 - nature.com
The division of medulloblastoma into different subgroups by microarray expression profiling
has dramatically changed our perspective of this malignant childhood brain tumour. Now, …

[HTML][HTML] The multidrug resistance protein family

P Borst, R Evers, M Kool, J Wijnholds - Biochimica et Biophysica Acta (BBA) …, 1999 - Elsevier
… In the best transfectants, 2008 ovarium carcinoma cells, we only observed marginal
resistance to vincristine and mitoxantrone (M. Kool, unpublished data). However, Cui et al. [46] …

Signatures of mutational processes in human cancer

…, N Jäger, DTW Jones, D Jones, S Knappskog, M Kool… - Nature, 2013 - nature.com
All cancers are caused by somatic mutations; however, understanding of the biological
processes generating these mutations is limited. The catalogue of somatic mutations from a …

Driver mutations in histone H3. 3 and chromatin remodelling genes in paediatric glioblastoma

…, M Tönjes, V Hovestadt, S Albrecht, M Kool… - Nature, 2012 - nature.com
Glioblastoma multiforme (GBM) is a lethal brain tumour in adults and children. However,
DNA copy number and gene expression signatures indicate differences between adult and …

DNA methylation-based classification of central nervous system tumours

…, M Kool, C Herold-Mende, DW Ellison, M Hasselblatt… - Nature, 2018 - nature.com
Accurate pathological diagnosis is crucial for optimal management of patients with cancer.
For the approximately 100 known tumour types of the central nervous system, standardization …

[HTML][HTML] Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma

…, E Pfaff, M Tönjes, M Sill, S Bender, M Kool, M Zapatka… - Cancer cell, 2012 - cell.com
Glioblastoma (GBM) is a brain tumor that carries a dismal prognosis and displays considerable
heterogeneity. We have recently identified recurrent H3F3A mutations affecting two …

Molecular subgroups of medulloblastoma: the current consensus

…, P Lichter, RJ Gilbertson, SL Pomeroy, M Kool… - Acta …, 2012 - Springer
Medulloblastoma, a small blue cell malignancy of the cerebellum, is a major cause of morbidity
and mortality in pediatric oncology. Current mechanisms for clinical prognostication and …

The landscape of genomic alterations across childhood cancers

…, KW Pajtler, M Kool, RM Piro, JO Korbel, M Schlesner… - Nature, 2018 - nature.com
Pan-cancer analyses that examine commonalities and differences among various cancer
types have emerged as a powerful way to obtain novel insights into cancer biology. Here we …

Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 …

M Kool, A Korshunov, M Remke, DTW Jones… - Acta …, 2012 - Springer
Medulloblastoma is the most common malignant brain tumor in childhood. Molecular studies
from several groups around the world demonstrated that medulloblastoma is not one …